170 related articles for article (PubMed ID: 22360685)
1. Protection of CDC25 phosphatases against oxidative stress in breast cancer cells: evaluation of the implication of the thioredoxin system.
Beillerot A; Battaglia E; Bennasroune A; Bagrel D
Free Radic Res; 2012 May; 46(5):674-89. PubMed ID: 22360685
[TBL] [Abstract][Full Text] [Related]
2. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
3. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells.
Myers CR; Myers JM
Toxicology; 2009 Mar; 257(1-2):95-104. PubMed ID: 19135121
[TBL] [Abstract][Full Text] [Related]
4. The thioredoxin system in breast cancer cell invasion and migration.
Bhatia M; McGrath KL; Di Trapani G; Charoentong P; Shah F; King MM; Clarke FM; Tonissen KF
Redox Biol; 2016 Aug; 8():68-78. PubMed ID: 26760912
[TBL] [Abstract][Full Text] [Related]
5. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231.
Turturro F; Friday E; Welbourne T
BMC Cancer; 2007 Jun; 7():96. PubMed ID: 17555594
[TBL] [Abstract][Full Text] [Related]
7. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
Prast-Nielsen S; Cebula M; Pader I; Arnér ES
Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-mimetic peptides (TXM) reverse auranofin induced apoptosis and restore insulin secretion in insulinoma cells.
Cohen-Kutner M; Khomsky L; Trus M; Aisner Y; Niv MY; Benhar M; Atlas D
Biochem Pharmacol; 2013 Apr; 85(7):977-90. PubMed ID: 23327993
[TBL] [Abstract][Full Text] [Related]
10. Expression of the thioredoxin system in an in vivo-like cancer cell environment upon auranofin treatment.
Bhatia M; Lovitt CJ; Raninga PV; Avery VM; Di Trapani G; Tonissen KF
Eur J Cell Biol; 2016 Oct; 95(10):378-388. PubMed ID: 27567536
[TBL] [Abstract][Full Text] [Related]
11. Studies toward novel peptidomimetic inhibitors of thioredoxin-thioredoxin reductase system.
Kłossowski S; Muchowicz A; Firczuk M; Swiech M; Redzej A; Golab J; Ostaszewski R
J Med Chem; 2012 Jan; 55(1):55-67. PubMed ID: 22128876
[TBL] [Abstract][Full Text] [Related]
12. Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells.
Cai W; Zhang B; Duan D; Wu J; Fang J
Toxicol Appl Pharmacol; 2012 Aug; 262(3):341-8. PubMed ID: 22634334
[TBL] [Abstract][Full Text] [Related]
13. Glutaredoxin 2 reduces both thioredoxin 2 and thioredoxin 1 and protects cells from apoptosis induced by auranofin and 4-hydroxynonenal.
Zhang H; Du Y; Zhang X; Lu J; Holmgren A
Antioxid Redox Signal; 2014 Aug; 21(5):669-81. PubMed ID: 24295294
[TBL] [Abstract][Full Text] [Related]
14. Potential Anticancer Activity of Auranofin.
Onodera T; Momose I; Kawada M
Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
16. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action.
Liang W; Fernandes AP; Holmgren A; Li X; Zhong L
FEBS J; 2016 Feb; 283(3):446-58. PubMed ID: 26546231
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide.
Pannala VR; Dash RK
Free Radic Biol Med; 2015 Jan; 78():42-55. PubMed ID: 25451645
[TBL] [Abstract][Full Text] [Related]
18. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
19. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
[TBL] [Abstract][Full Text] [Related]
20. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
